Dr. Edlow received his B.A. from Princeton University and M.D. from the University of Pennsylvania School of Medicine. He completed an internal medicine internship at Brigham and Women's Hospital, followed by neurology residency and neurocritical care fellowship at Massachusetts General and Brigham and Women’s Hospitals. He is currently a critical care neurologist at Massachusetts General Hospital, where he is Associate Professor of Neurology, Associate Director of the Center for Neurotechnology and Neurorecovery, and Director of the Laboratory for NeuroImaging of Coma and Consciousness.  Dr. Edlow's research focuses on detecting consciousness, predicting outcomes, and developing new therapies for patients with severe traumatic brain injury.  His lab’s work has been continuously funded since 2010 by grants from the NIH, DOD, and multiple foundations. He is the recipient of the 2019 NIH Director’s New Innovator Award and the 2022 ANA Derek Denny-Brown Young Neurological Scholar Award.  Dr. Edlow serves on the Scientific Advisory Board of the Neurocritical Care Society’s Curing Coma Campaign, the Editorial Board of the Journal of Neurotrauma, and is Co-Chair of the NINDS Common Data Elements Project on Disorders of Consciousness.  He also serves as the Principal Investigator of the SOCOM-funded ReBlast study, which aims to identify diagnostic biomarkers of blast-induced brain injury in United States Special Operations Forces Service Members.